Web Analytics

Metabolic alterations driven by LDHA in CD8 + T cells promote immune evasion and therapy resistance in NSCLC



Metabolic alterations driven by LDHA in CD8 + T cells promote immune evasion and therapy resistance in NSCLC



Summary

Lung cancer cells often evade the immune system by manipulating CD8+ T cells, the body’s primary cancer-fighting soldiers. This research highlights the crucial role of LDHA, an enzyme involved in energy production, within these T cells. In non-small cell lung cancer (NSCLC), LDHA activity is increased in CD8+ T cells, leading to metabolic changes that hinder their ability to kill cancer cells. Specifically, LDHA promotes the production of inhibitory molecules and reduces the T cells’ effector function. Ultimately, this LDHA-driven metabolic shift contributes to immune evasion by the cancer cells and reduces the effectiveness of cancer therapies. Targeting LDHA may therefore be a promising strategy to enhance the immune response against NSCLC.

Read more…

Credits: Source

This post is part of “Science/Immunology News”, Follow for more…!!!


Discover more from abdullahfarhan.com

Subscribe to get the latest posts sent to your email.

Dr AF Saeed

Related post

Thank you for Visiting. Leave a Reply!

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.